Novartis AG

NVS

Company Profile

  • Business description

    Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

  • Contact

    Lichtstrasse 35
    Basel4056
    CHE

    T: +41 613241111

    E: [email protected]

    https://www.novartis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    76,057

Novartis AG News & Analysis

stocks

Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?

‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
stocks

Best international companies to own: 2023 Edition

These companies from various corners of the globe are well positioned for the future.
markets

Asian markets are globalising

In an era of onshoring and localisation, revenue sources show an increasingly interconnected world economy

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,567.0012.10-0.14%
CAC 407,213.3214.870.21%
DAX 4019,146.17141.390.74%
Dow JONES (US)43,948.27539.801.24%
FTSE 1008,149.2764.200.79%
HKSE19,601.11103.90-0.53%
NASDAQ19,025.4459.300.31%
Nikkei 22538,026.17326.17-0.85%
NZX 50 Index12,765.2428.180.22%
S&P 5005,960.7843.670.74%
S&P/ASX 2008,323.003.30-0.04%
SSE Composite Index3,370.402.410.07%

Market Movers